Colgate-Palmolive is dealing with a stubborn problem in its home market. North American sales weakened again in the second quarter of 2026, putting more pressure on the consumer products giant to get shoppers interested in its brands.

The company is not responding with sweeping discounts or a major retreat. Instead, Colgate-Palmolive is spending more on advertising, pushing premium products, improving margins, and using cost savings to support future growth.

Investors are also getting something familiar while management works through the slowdown. Colgate-Palmolive continues to deliver one of the longest-running dividend records among major U.S. companies. The board declared another quarterly dividend of $0.53 per common share in September. It will be paid on November 13, 2026, to shareholders of record on October 20. The annualized dividend rate stands at $2.12 per share.

Colgate-Palmolive's Dividend Keeps Its Long Streak Alive

Magda / Pexels / Colgate-Palmolive has paid uninterrupted dividends on its common stock since 1895. Even more impressive, the company has increased payments to common shareholders every year for 63 straight years.

That kind of consistency helps explain why the dividend remains a major part of the Colgate-Palmolive investment story. Toothpaste and dish soap may not generate much excitement on Wall Street, but steady consumer demand can produce dependable cash flow.

The latest dividend increase arrived in March 2026. Colgate raised its quarterly payout from $0.52 to $0.53 per share, lifting the annualized rate from $2.08 to $2.12.

The increase was small, but the pattern matters more than one year's jump. Colgate has kept raising its payout through recessions, inflation shocks, market crashes, and major changes in consumer behavior.

The company generated $1.742 billion in operating cash flow during the first six months of 2026. That gives management room to support dividends while continuing to spend on advertising, new products, and business improvements.

Colgate also entered the second half with stronger margins. Its Q2 gross profit margin reached 61.5%, up 140 basis points from a year earlier. Management's cost-saving work contributed heavily to that improvement.

Premium Products Get More Attention as U.S. Sales Slip

North America remains the uncomfortable part of the story. Colgate-Palmolive reported that North American net sales fell 3.0% in the second quarter, while organic sales also declined 3.0%.

Volume was even weaker, falling 3.9%, while pricing added 0.9%. The numbers followed a difficult first quarter, when North American organic sales had already fallen 2.2%.

That performance stands in sharp contrast with several international markets. Latin American net sales jumped 13.7% in Q2, while Asia Pacific sales rose 4.9%. Europe, the Middle East and Africa posted a 3.5% increase.

The global mix helped Colgate-Palmolive keep growing despite the U.S. weakness. Total company net sales increased 4.9% to $5.361 billion, while organic sales grew 2.4%. Management is trying to improve North American performance through more innovation, particularly at higher price points. That means giving shoppers a stronger reason to spend extra rather than relying heavily on broad discounts.

Colgate Optic White Pro Series with ActivShine Technology is one example. The company has put marketing support behind the premium toothpaste as it tries to strengthen its position in higher-value parts of the oral care aisle.

Strong Global Results Give Colgate Room to Fix North America

E Online / The encouraging part for Colgate is that weak North American sales have not pulled the whole company backward. Q2 net sales increased 4.9%, and growth came from three of four product categories and four of five geographic divisions.

Underlying earnings also moved higher. Base Business earnings per share reached $0.99, an 8% increase from $0.92 a year earlier.

GAAP earnings told a different story because of costs that Colgate excludes from its Base Business measure. GAAP diluted earnings per share fell 5% to $0.86 from $0.91. The company also maintained its full-year sales outlook after the quarter. Colgate expects 2026 net sales to increase between 2% and 6%, including a low-single-digit benefit from foreign exchange.